Purpose The anterior cruciate ligament (ACL) is known to have a poor healing ability, especially in comparison with the medial collateral ligament (MCL) which can heal relatively well. Interleukin-1beta (IL-1β) is considered to be an important chemical mediator in the acute inflammatory phase of ligament injury. The role of IL-1β-induced expressions of lysyl oxidases (LOXs) and matrix metalloproteinases (MMPs), which respectively facilitate extracellular matrix (ECM) repair and degradation, is poorly understood. In this study, we aim to determine the intrinsic differences between ACL and MCL by characterising the differential expressions of LOXs and MMPs in response to IL-1β in the injury process. Methods Semi-quantitative polymerase chain reaction (PCR), quantitative real-time PCR, Western blot, and zymography were performed. Results We detected high expressions of IL-1β-induced LOXs in normal ACL and MCL. Then, we found IL-1β induced injured MCL to express more LOXs than injured ACL (up to 2.85-fold in LOX, 2.58-fold in LOXL-1, 1.89-fold in LOXL-2, 2.46-fold in LOXL-3 and 2.18-fold in LOXL-4). Meanwhile, we found IL-1β induced injured ACL to express more MMPs than injured MCL (up to 1.72-fold in MMP-1, 1.95-fold in MMP-2, 2.05-fold in MMP-3 and 2.3-fold in MMP-12). The further protein results coincided with gene expressions above. Conclusions Lower expressions of LOXs and higher expressions of MMPs might help to explain the poor healing ability of ACL.
Introduction
The anterior cruciate ligament (ACL) and medial collateral ligament (MCL) are two commonly injured areas of knee joints [1, 2] . In general, the MCL has the capacity to selfheal and restore joint function of a completely ruptured mid-substance within one month, and in most cases, without the need for surgery [3, 4] . On the other hand, the ACL does not heal satisfactorily, even if surgical repair is attempted [5] , and ACL injuries often lead to knee instability, pain and even progressive degeneration of other joint tissues [6, 7] .
Ligament healing is a complicated process which contains old extracellular matrix (ECM) collagen degradation and new ECM collagen synthesis and deposition [5, 8] . Failure to heal could be influenced by a lower potential for structural protein synthesis leading to a lower amount of scar tissue formation or rapid degradation of ligament substance following injury, or both [9] . Interleukin-1beta (IL-1β) is a strong pro-inflammatory cytokine that appears in the knee joint immediately after ligament injury and remains there through the following days [10] [11] [12] . IL-1β works both directly and indirectly on ligament injury by binding to its receptors and initiating a cellular response [10, 13] . Kondo and Ohshima's research using a skin wound model in mice suggested a close relationship between IL-1β, the migration of fibroblasts and the formation of new granulation tissue [14] . However, the healing potential of intra-articular soft tissues is generally lower than an ordinary wound. To better understand the different healing abilities of ACL and MCL, we focused on the lysyl oxidases (LOX) and matrix metalloproteinases (MMP) response to IL-1β.
The LOX family has the capability of oxidising peptidyl lysine to peptidyl aldehyde residues within collagen, thus initiating formation of the covalent cross-linkages that precipitate these extracellular proteins, which facilitates the formation and repair of ECM [15, 17, 18, 45] . The LOX family contains five members characterised by conserved Cterminal copper binding and functional catalytic domains. They include LOX [18] , LOX-like proteins 1 (LOXL-1) [19] , 2 (LOXL-2) [20] , 3 (LOXL-3) [21] and 4 (LOXL-4) [22] , whose residue lengths are 417, 574, 638, 753 and 756 kDa, respectively. Compared with the significant homology within the C-terminal domains that appear among the human LOX family, there is little homology in the Nterminal regions of these proteins with the LOX propeptide domain [18] . As for the relationship between LOXs and IL-1β, previous data were mainly based on adult skin fibroblasts [23] and human lung fibroblasts [24] .
MMPs play an important role in ECM degradation of ligaments [9, 25] . They could cleave one or more of the components of the ECM of ligaments. MMP-1 has the capability to cleave interstitial collagens I, II and III at a specific site relative to the N terminus [26] . MMP-2 containing three repeats of a type II fibronectin domain in the catalytic domain which bind to gelatin, collagens and laminin [27] can degrade gelatin as well as type I and III collagens [28] . MMP-3 has substrates including collagen type III, IV, V, VII, IX, X and XI, and also has activity against gelatin type I and elastin [29] ; furthermore, it has a pivotal role in activating other MMPs [30] . The newest member of the stromelysin subgroup, MMP-12, is clearly the most active MMP against elastin [31] , but it is also able to cleave, e.g. fibronectin, type IV collagen, and laminin-1 [32] ; additionally, it has been shown to up-regulate the inflammatory response by stimulating the release of tumour necrosis factor alpha (TNF-α) from pro-TNF-α fusion protein [33] .
Here, we investigate the intrinsic differences between the poor self-healing adult ACL and the relatively good selfhealing adult MCL by characterising the differential expressions of LOXs and MMPs in response to IL-1β in the injury process. We mimicked injured ACL and MCL in vitro by an equibiaxial stretching chamber [43, 44] and sought to elucidate the differential variations of cross-linked enzyme LOXs and matrix-degraded protease MMPs in an injured ACL/MCL comparison model.
Materials and methods

Cell culture
The human materials used for this study were obtained according to ethical principles and the protocol was reviewed and approved by our Institutional Review Board. Human ACL and MCL fibroblasts were harvested from six donor tissues with an age from 23 to 56 as described previously [41] . In short, the donor ligament tissues were collected from patients who underwent total knee replacement surgery at the First Affiliated Hospital of Chongqing Medical University, Chongqing, China. The samples were immediately washed with 1×phosphate-buffered saline (PBS) and cut into small pieces of dimension 2 × 2 × 2 mm 3 (peri-portion of ACL tissue was discarded to avoid peri-fibroblast contamination). The small pieces of ligament were suspended in 10 % foetal bovine serum (FBS) media (low-glucose DMEM, 0.1 mM nonessential amino acids, 4 mM L-glutamine and antibiotics) and incubated at 37°C in a humidified atmosphere of 5 % CO 2 and 95 % air. After the fibroblasts migrated out from small tissues and attached to the bottom, the tissues were transferred to another flask and the remaining cells were allowed to grow to confluence. The cells were then frozen into arrest growth with liquid nitrogen. Cells were then cultured in 10 % FBS-DMEM at 37°C in a humidified atmosphere of 5 % CO 2 and 95 % air. Experiments were carried out with cells from only passage 3 to passage 5. Cells from six different donor patients were used separately in the experiments. Experiments were repeated at least three times.
In vitro injury
The area inside each stretch chamber was coated with 5 pg/ ml poly-D-lysine (MW 220,000: Sigma, St. Louis, MO, USA) at 37°C for 40 minutes and then washed twice with PBS to remove unattached poly-D-lysine. The substrate molecule, collagen I (Sigma), was coated at concentrations of 5 pg/ml for 30 minutes at 37°C. Excess collagen was washed away with two rinses of PBS and the chambers were then incubated with 0.5 % bovine serum albumin in PBS to prevent cell adhesion to areas of poly-D-lysine left uncovered by the collagen. Cells were trypsinised and seeded onto the collagen I-coated silicone membrane within an equibiaxial stretch chamber [43, 44] at the concentration of 10 7 cells per chamber (90-95 % confluence). Cells were allowed 24 hours to seed and equilibrate. Then, the culture media were removed and replaced by 2 % FBS media for 16 h for starvation. Right before stretching, the culture media were replaced with 1 % FBS fresh media. ACL and MCL cells were subjected to injurious (12 %) and control (0 %) stretch conditions. Then, 600 μl culture media samples were collected at 12, 24, 48 and 72 hours for protein expressions; 1,000 μl cell lysate samples (according to the RNA Isolation Kit, Qiagen, Hilden, Germany) were collected at zero, two, six, 12 and 24 hours for gene expressions.
IL-1β treatment
Cells were seeded onto the collagen I-coated silicone membrane within an equibiaxial stretch chamber. Cells were allowed 24 hours to seed and equilibrate. Then, the culture media were removed and replaced by 2 % FBS media for 16 hours for starvation. Right before being treated with IL-1β (PeproTech, Rocky Hill, NJ, USA) at different concentrations (1, 5 and 20 ng/ml), the culture media were replaced with fresh 1 % FBS media and cells were subjected to control (0 %) and injurious (12 %) stretch. Samples of 1,000 μl cell lysates were collected two hours after treatments with 1, 5 and 20 ng/ml IL-1β for semi-quantitative polymerase chain reaction (PCR) and quantitative real-time PCR assays; at 5 ng/ml, samples were collected at zero (control), two, six, 12 and 24 h after IL-1β treatments. At the protein level, samples of 500 μl cell lysates and 600 μl culture media were collected at 72 hours for Western blot of LOXs; 600 μl culture media were collected at 12, 24, 48 and 72 hours for zymography of MMP-2.
Semi-quantitative PCR
RNA samples from cells at two, six, 12 and 24 hours after IL-1β treatments in normal and injured ACL/MCL fibroblasts were isolated using the RNeasy Plus Mini Kit (Qiagen) with a genomic DNA eliminator, according to the manufacturer's instructions. Isolated RNA was dissolved in RNAse-free water and quantified by measuring the absorbance at 260 nm with a spectrophotometer. The RNA samples were then treated with DNAse I (Mbi, Glen Burnie, MD, USA), and cDNA was prepared for each sample, using 0.5 mg of total RNA and the cDNA synthesis kit (Mbi) in a final volume of 20 μl.
To evaluate the expression levels of LOXs and MMPs in both ACL and MCL normalised to the housekeeping glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene (or beta-actin gene, we finally displayed GAPDH as the control gene), semi-quantitative PCR was performed with a PCR kit (Mbi) using a thermal cycler (Bio-Rad, Hercules, CA, USA) according to described techniques. PCR primer pairs of these genes were designed using Primer5.0. The selected sets of primers are shown in Table 1 . The BLAST was used to search for all primer sequences to ensure gene specificity. Semi-quantitative PCR reactions were performed in a 25 μl volume containing 1 μl cDNA sample following the manufacturer's recommendations (here we used the OD method to detect the isolated mRNA concentration to make sure the total mRNA was suited for reactions). PCR consisted of an initial 30 second denaturising at 94°C, 30 second for annealing at 55-65°C and 72°C, 30 second for elongation and 25-28 amplification cycles (to make sure the reaction is finished at exponential amplification zone). Products were resolved by 2 % agarose gel electrophoresis in Tris-borate/ethylenediaminetetraacetic acid (EDTA) buffer and visualised by staining with ethidium bromide.
Quantitative real-time PCR Quantitative real-time PCR was performed with Quanti-Tect SYBR Green PCR Kit (Qiagen) using iCycler (Bio-Rad) according to described techniques. PCR reactions were performed at 0.5 μM for each primer in a 25 μl volume containing 1 μl cDNA sample. The reaction was initiated by activating the polymerase with a 5-min pre-incubation at 95°C. Amplification was achieved with 45 cycles of 15 seconds denaturation at 94°C, 20 s annealing at 65°C and ten seconds extension at 72°C. The programme was concluded by a melting curve analysis. All experiments were Proteins were visualised via chemiluminescence with hydrogen peroxide using Kodak X-AR and luminol as substrate.
Zymography MMP-2 activity was assayed from the collected culture media samples using 0.05 % gelatin zymography. Briefly, 10 ml of each sample was mixed with an equal amount of Laemmli Sample Buffer (62.5 mM Tris-HCl, pH 6.8, 25 % glycerol, 2 % SDS, 0.01 % bromophenol blue, no β-mercaptoethanol) and separated on a 10 % SDS-PAGE gel that was copolymerised with 0.05 % gelatin. To regain enzyme activity by removing the SDS, gels were washed three times for 1.5 hours in 2.5 % Triton X-100 at RT after electrophoresis. Washed gels were then bathed in proteolysis buffer (50 mM CaCl 2 , 0.5 M NaCl, 50 mM Tris, pH 7.8) and incubated at 37°C for 15 hours. Following incubation, gels were rinsed in a 2.5 % Triton X-100 solution and stained at room temperature with Coomassie blue (45 % methanol, 44.75 % H 2 O, 10 % acetic acid, 0.25 % Coomassie blue R-250) for one hour on a rotator. Gels were destained (40 % methanol, 7.5 % acetic acid, 52.5 % H 2 O) until white bands appeared clearly from the Coomassie blue background. Bands were scanned using a densitometer (Bio-Rad), and quantification was performed using Quantity One 4.6.3 software (BioRad).
Statistical analysis
Statistical analysis was performed by one-way analysis of variance (ANOVA) to determine whether differences existed among groups. Post hoc analysis used Fisher's protected least significant differences (PLSD). In each analysis, the critical significance level was set to be p<0.05.
Results
Cell viability
No cytotoxic effects of exogenous inflammatory factor IL-1β were observed on the ACL and MCL cells at the different doses used in this study by trypan blue staining. Additionally, in our lab, cell activities of ACL and MCL were determined using the MTT assay, which is based on the mitochondrial conversion of the tetrazolium salt, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide. Increasing doses of IL-1β did not significantly alter cell viability in our lab (IL-1β up to 50 ng/ml).
IL-1β promoted gene expressions of the LOX family in normal ACL and MCL fibroblasts
To determine the effects of IL-1β on expressions of the LOX family, ACL and MCL fibroblasts were treated with 0 (control), 1, 5 and 20 ng/ml IL-1β for the indicated time courses. The gene expressions of LOXs were detected by semi-quantitative PCR (Fig. 1a) and quantitative real-time PCR (Fig. 1b) . We observed that IL-1β induced gene expressions of LOXs in a dose-dependent manner in ACL and MCL fibroblasts. Moreover, expressions of IL-1β-induced LOXs in MCL were higher than those in ACL fibroblasts. Specifically, at 20 ng/ml, LOX was 1.87±0.15-and 2.47±0.17-fold in ACL and MCL compared to non-treated controls, respectively; LOXL-1 1.72±0.11-and 2.53±0.13-fold; LOXL-2 2.55± 0.14-and 3.12±0.13-fold; LOXL-3 1.52±0.10-and 2.74± 0.16-fold; LOXL-4 2.11±0.15-and 2.95±0.13-fold. From 
IL-1β induced higher expressions of the LOX family in injured MCL than those in injured ACL fibroblasts
We used an equibiaxial stretch chamber to injure ACL and MCL cells, and then we treated these cells with 5 ng/ml IL-1β. As the time points at which a gene responds to stimulus vary, Fig. 1 IL-1β we determined the mRNA levels of LOX family genes at 0 (control), 2, 6, 12 and 24 hours after initiation of the 12 % injury stretch and 5 ng/ml IL-1β. We found that almost mRNA level peaks of LOXs were at 12 hours, except for LOX and LOXL-4 in ACL (at six hours). Specifically, IL-1β induced injured MCL to express more LOXs than normal MCL fibroblasts, while in ACL, although IL-1β upregulated LOXs expressions in both normal and injured cells, the IL-1β induced injured ACL to express less LOXs compared with normal ACL as time points varied (Fig. 2) . As we focused on the role of cross-linkage of LOX in the ECM, we further collected culture media to analyse LOX expressions at the protein level (cell lysates for β-actin as control). The culture media were collected at 72 hours after 5 ng/ml IL-1β treatments. We found 5 ng/ml IL-1β promoted higher expressions of LOX in both normal ACL and MCL fibroblasts compared with non-treated controls (up to 204 % in ACL and 225 % in MCL). In the injured state, IL-1β induced LOX expression up to 175 % in ACL and 293 % in MCL (Fig. 3) .
IL-1β induced higher levels of MMPs in injured ACL than those in injured MCL fibroblasts MMPs were known for their roles in ECM degradation after injury. Our lab previously reported the increases of MMPs in ACL and MCL fibroblasts after 12 % mechanical stretch injury [5, 8] . We further determined inflammatory factor IL-1β-induced MMPs in both ACL and MCL fibroblasts. We collected samples at 0 (control), 2, 6, 12 and 24 hours after initiation of 5 ng/ml IL-1β treatments in normal and injured ACL/MCL. We found MMP-1, -2 and -12 were highly expressed in injured ACL and MCL; furthermore, the expression peaks of MMP-1, -2 and -12 were all higher in injured ACL than those in MCL (MMP-1 9.30±0.80-fold in ACL and 5.40±0.60-fold in MCL compared to control; MMP-2 6.72±0.70-and 3.91±0.65-fold; MMP-12 11.91± 0.9-and 5.80±0.81-fold) (Fig. 4a) . Semi-quantitative PCR detected that MMP-3 was higher in injured ACL than that in MCL (Fig. 4b) .
We then collected culture media at 12, 24, 48 and 72 hours after IL-1β treatments in normal and injured ACL/MCL fibroblasts. Activities of MMP-2 were detected using zymography (Fig. 5) . We found IL-1β-induced MMP-2 activities in normal and injured ACL were prominently higher than MCL. Specifically, at 72 hours, IL-1β-induced MMP-2 activity in injured ACL was up to 6.14±0.32-fold higher compared to control, while in injured MCL, activity of MMP-2 was 2.92±0.28-fold higher than control.
Discussion
An essential feature of wound healing is controlled proteolytic degradation and remodelling of the ECM [31, 38, 39] . Wound repair of the connective tissue matrix also undergoes this process including the inflammatory phase, the reparative phase and the remodelling phase [9, 16] . Furthermore, the interactions between the dynamically altered matrix and the inflammatory, reparative and remodelling responses are reciprocal [16] .
Inflammation is the initial response to any tissue injury. The inflammatory cytokines play an important role in the wound healing mechanism, especially during the inflammatory phase [34] [35] [36] . The acute inflammatory response usually lasts between 24 and 48 hours and may persist for up to two weeks in some cases [11, 37] . In ligament fibroblasts, a high level of inflammatory factor IL-1β appeared within 24 h of ACL and MCL injury, and there were variable changes in IL-1β through the following days [5, 8] .
More and more evidence has indicated the relationship between LOXs and wound healing [15, 18, [45] [46] [47] . The role of each family member towards ECM cross-linkage has been consecutively identified [45, [48] [49] [50] [51] . However, the The data for each sample were normalised to GAPDH mRNA. Data (means±SD, n04) were represented as the fold change in expression compared to control. *p<0.05. b The mRNA of MMP-3 in ACL and MCL cells were too low to detect using quantitative real-time PCR by the △Ct method loading 1 μl cDNA coordinate with other MMPs. Through GAPDH using semiquantitative PCR with 38 cycles, increased gene expressions reached value peaks at 6 h after 5 ng/ml IL-1β in injured ACL and MCL. Notably, the ratio of MMP-3 mRNA (injured ACL to MCL) was high. The data were the mean of four different experiments (n04). *sSgnificant difference with respect to control (p<0.05) relationship between IL-1β and LOXs in ligament healing was barely recorded. From our data, we could see IL-1β upregulated expressions of LOXs in normal and injured ACL/ MCL fibroblasts. The results were coincident with those previously reported in adult skin fibroblasts [23] and human lung fibroblasts [24] . Furthermore, the up-regulated LOXs induced by IL-1β were higher in MCL than those in ACL at normal and injured states, respectively (Figs. 1, 2 and 3) . Additionally, in ACL fibroblasts, IL-1β-induced LOXs were higher in normal cells compared to injured cells, while in MCL, IL-1β promoted injured cells to express more LOXs than normal cells. In other words, after IL-1β treatment, the injured MCL could express much more mRNAs of the LOXs compared with injured ACL fibroblasts. Since LOX enzymes participate in ECM formation and repair, the result may provide an explanation concerning the better healing response of MCL injury in comparison to that of ACL.
MMPs are Zn 2+ -dependent endoproteinases, which were initially classified into three groups based on their substrate specificities [40] . The three groups are collagenases (such as MMP-1), gelatinases (MMP-2 and MMP-9) and stromelysins (such as MMP-12). Our previous data [41] showed that, after injury, MMP-1 increased up to 2.76-fold in ACL, but showed no significant change in MCL cells. MMP-2 showed up to 4.29-fold increase in ACL compared with MCL and activities showed a time-dependent manner. MMP-3 and MMP-12 seem without significant change in both ACL and MCL. In this study, we found that, after injury, IL-1β could induce higher expressions of MMPs above. MMP-1 increased up to 9.3-fold in ACL, while 5.2-fold in MCL; MMP-2 up to 6.7-fold in ACL and 3.9-fold in MCL; MMP-12 up to 11.8-fold in ACL and 5.9-fold in MCL (Fig. 4a) . Then we detected MMP-3; we found that although there was no significant change in injured ACL and MCL, in vitro IL-1β enhanced injured ACL and MCL to express MMP-3, the ratio of mRNAs (ACL to MCL) was up to 2.1-fold (Fig. 4b) .
Previously, our lab has also reported that MMP-2 production is directly related to ACL fibroblast repair [8] . Two forms (62 and 72 kDa) carry out the same enzymatic reaction, but the 72 kDa MMP-2 has approximately 10 % the activity of the 62 kDa MMP-2 [5] . Here we found that after treatment with 5 ng/ml IL-1β, there was a significant timedependent increase in the production of the 72 kDa MMP-2 c The indicated quantitative data refer to 72-h time points of control and treated groups, respectively. Besides, the band 62 kDa active form MMP-2 was calculated as 10 times density of the 72 kDa pro-MMP-2 band as described previously [5, 8] . The data were the mean of four different experiments (n04). *Significant difference with respect to control (p<0.05) in normal and injured ACL/MCL fibroblasts (Fig. 5a) . The increased MMP-2 activities were obviously higher in injured ACL than in injured MCL, and the active form (62 kDa) of injured ACL was more prominent compared to injured MCL. The high levels of MMPs in injured ACL may provide another explanation of its poor self-healing ability.
We concentrated on the influence of pro-inflammatory cytokine IL-1β on LOXs and MMPs in injured ACL and MCL, but this only partially mimicked real injury conditions. The ligament-specific factors including cellular properties [42] and actual environmental factors including nutrient delivery, biomechanical forces and synovial fluid [5, 8, 36] may modulate the levels of LOXs and MMPs released from injured ACL and MCL. In the actual injury state, all factors may exert the effects together to induce LOX and MMP expressions during the injury cascade.
In summary, pro-inflammatory cytokine IL-1β induced higher expressions of MMPs, and relatively lower LOXs in injured ACL compared with those in injured MCL fibroblasts might explain the poor self-healing capacity of ACL. Seek factors or combined factors which could inhibit the activities of MMPs and promote activities of LOXs might increase the strength of the repaired injured ACL to a level where there would be no need for reconstructive surgeries.
